During the past decade, Praxis fur Hamatologie und internistische Onkologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Praxis fur Hamatologie und internistische Onkologie" are "Breast Cancer" (1 trials), "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials), "Early Breast Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Praxis fur Hamatologie und internistische Onkologie" in a lesser frequency.

Most popular intervention types in "Praxis fur Hamatologie und internistische Onkologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Gemcitabine" (2 trials), "Pemetrexed" (2 trials), "Vinorelbine" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis fur Hamatologie und internistische Onkologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Praxis fur Hamatologie und internistische Onkologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Praxis fur Hamatologie und internistische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis fur Hamatologie und internistische Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".